Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
Accounts Payables history
Currency unavailable · from the cash flow
No Accounts Payables data reported for this period type.
Accounts Payables vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $81.11M USD | +53.9% | — | 34.9% | |
ORKAOruka Therapeutics, Inc. | LTM Sep 2026 | $12.17M USD | +5581.5% | — | — |
| LTM Mar 2026 | $8.3M USD | +286.2% | +184.2% | 99.2% | |
| LTM Mar 2026 | $4.41M USD | +702.6% | +15.7% | — | |
ALMSAlumis Inc. Common Stock | LTM Jun 2026 | $2.18M USD | +391.0% | — | 29.5% |
| LTM Sep 2026 | $1.46M USD | +112.4% | — | 1.6% | |
| LTM Jun 2026 | $214K USD | +223.7% | +22.1% | 0.1% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | — | — | — | — | — |
| Peer median (excluding ODTX) | — | +286.2% | +22.1% | 29.5% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.